Related Experiment Video
Updated: Nov 23, 2025
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.5K
Identifying biomolecules and constructing a prognostic risk prediction model for recurrence in osteosarcoma
Minglei Zhang1, Yang Liu2, Daliang Kong1
1Departments of Orthopaedics, China-Japan Union Hospital of Jilin University, No.126, Xiantai Street, Changchun, Jilin 130033, China.
Journal of Bone Oncology
|December 30, 2020
Summary
This study identifies seven RNA signatures as novel prognostic biomarkers for osteosarcoma recurrence. A nomogram integrating these signatures and clinical factors predicts patient survival, aiding personalized treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Osteosarcoma presents a high morbidity and poor prognosis.
- There is a critical need for effective prognostic biomarkers and prediction models for osteosarcoma recurrence.
Purpose of the Study:
- To identify novel RNA signatures for predicting osteosarcoma recurrence.
- To develop a prognostic risk prediction model for osteosarcoma patients.
Main Methods:
- Microarray data analysis to screen for prognostic RNA signatures.
- Univariate and multivariate Cox regression analyses for signature screening and model building.
- Nomogram construction integrating RNA signatures, age, recurrence, and metastatic status for survival prediction.
Main Results:
- Seven RNA signatures (one lncRNA, six mRNAs) were identified as independent predictors of overall survival.
- A prognostic nomogram demonstrated strong predictive performance with C-index values of 0.809 (3-year) and 0.740 (5-year).
- Age, recurrence, and metastatic status were also confirmed as independent prognostic factors.
Conclusions:
- Seven novel RNA candidates show potential as prognostic biomarkers for osteosarcoma.
- Developed nomograms offer accurate, individualized survival predictions for osteosarcoma patients, aiding clinical decision-making.
